bilaterals.org logo
bilaterals.org logo

India FTAs & medicines

Can a US-India trade deal permanently alter the way Indians access medicines?
25-Feb-2020 The Wire
US-India IP engagements since 2006 have served the interests of the US through systematic undermining of the legislative safeguards in the Indian Patents Act.
India, Indonesia negotiating economic cooperation agreement
27-Jan-2020 Sunday Guardian Live
India and Indonesia are set to launch negotiations for a Comprehensive Economic Cooperation Agreement (CECA) to cover economic cooperation while trading in goods, services, and investments.
As Modi visits US, what does the free trade pact mean for India’s pharma industry?
25-Sep-2019 The Wire
A Free Trade Agreement with the US will likely result in the amendment of the Patents Act, which could impact the Indian pharma industry.
MSF statement on resumption of EU-India FTA negotiations
11-Apr-2018 MSF Access Campaign
Officials from the European Union (EU) and India are expected to meet in Brussels on April 12th to resume technical talks on the long-stalled EU-India free trade agreement (FTA). A leaked draft of the agreement, which has been under discussion since 2007, contains proposals from the EU that push for intellectual property (IP) provisions in the FTA that could jeopardize access to affordable medicines.
Delhi’s RCEP talks on intellectual property shouldn’t forget India’s role as ‘Pharmacy of the World’
5-Feb-2018 The Wire
India must resist pressure from Japan and South Korea in RCEP for the elevated levels of intellectual property provisions and make sure the deal doesn’t limit the production of life-saving generic drugs in India and for many other developing countries of the world.
India-Cambodia deliberates on financial support in agriculture, pharmaceuticals
30-Jan-2018 Knowledge & News Network
India and Cambodia clinch a deal to work towards a Bilateral Investment Treaty which provides financial help to Southeast Asian nations.
FTA with Peru: India may have to lower import duty on drugs
17-Jan-2018 The Hindu BusinessLine
India may have to lower the import duty on pharmaceuticals for Peru in the discussions on the proposed free trade agreement (FTA) with the South American country.
Israel set to make a strong push for goods FTA
12-Jan-2018 The Hindu BusinessLine
The present Indian government has relaunched the talks with Israel. Israel wishes to conduct talks on regular basis to conclude the deal at the earliest. Indian patent system and pharmaceutical related issues have been the reasons why the deal couldn’t progress.
RCEP: India in a Catch-22
10-Jan-2018 Deccan Herald
India’s position in the RCEP is the most protectionist among all the member nations. India has been resisting demands from Korea & Japan on intellectual property clauses, and other nations on opening up markets.
As India set to sign FTA with Peru, govt seeks industry views on export import duty rates
9-Jan-2018 PharmaBiz.com
If the trade equation between India and Peru is in imbalance it would be causing more harm than benefit to India.
India to oppose anti-generics proposals at RCEP meet
25-Oct-2017 Livemint
India firm in opposing proposals that could hinder global access to affordable generic drugs
India will not cross red lines on generic drugs in RCEP, but stay vigilant, say officials
25-Oct-2017 The Wire
Healthcare watchers are calling on India to resist RCEP
Access to affordable stents and other medical devices – Indian Government should reject the bullying tactics of the US based medical device industry
25-Oct-2017 Don’t trade our lives away
Access to health products is non-negotiable; the Indian Government should reject the bullying tactics of the US based medical device industry.
RCEP negotiations should not restrict global access to affordable medicines and vaccines
21-Oct-2017 MSF
RCEP negotiations should not restrict global access to affordable medicines and vaccines
Free trade talks with EFTA grouping hit IPR, services wall
26-Sep-2017 The Hindu
Switzerland insists on intellectual property commitments beyond TRIPS.
Neelam Deo on EU-India’s perplexing relationship: Trade, Europe’s hypocrisy and China concern
23-Aug-2017 EU Bulletin
Former diplomat says the EU’s insistence on opening up on wine imports from France and automobile imports from Germany have held up the EU-India FTA negotiations.
Big pharma, IP wars and profit over people
21-Aug-2017 Governance Now
At RCEP negotiations held in India, intellectual property rights issues in medicine remain contentious
Interview with Loon Gangte
4-Aug-2017 bilaterals.org
Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.
Trading health through IPR, patents
17-Jul-2017 Deccan Herald
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
30-May-2017 MSF
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.